CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Vaccine Delivery Across the Country Faces Supply Chain Challenges

Life Sciences Review | Tuesday, February 09, 2021
Tweet

FREMONT, CA: With the news that Moderna has applied for emergency use authorization for its coronavirus vaccine, and that Pfizer and BioNTech shot has been approved  in the UK the US is inching ever closer to having one, if not two, vaccines approved for use. Both are mRNA vaccines, which trigger cells to build proteins that look like coronavirus and thus set off an immune response. The UK regulator’s decision marks the first time an mRNA vaccine has been approved for use in humans. And, that aside, these two shots have been developed on a record-setting timeline that some experts hope will become the new normal.


Whereas only about half of US adults said they would get vaccinated in September, new research from Pew has found that 60 percent now say they would definitely or probably get vaccinated against Covid-19 today if they could But that still leaves a significant number of Americans who say they would not get the vaccine, many of whom also reported that more information wouldn’t change their minds. This lack of trust in vaccines could exist for any number of reasons, including the country’s long history of medical racism and the rapid spread of vaccine misinformation online. In the hopes of building public trust, former presidents Barack Obama, George W. Bush, and Bill Clinton recently announced they will all get vaccinated as soon as possible, and may even film the process.


There is also the question of how quickly pharmaceutical companies can manufacture and distribute a new and complicated vaccine. Pfizer and BioNTech had planned to produce 100 million doses for use worldwide by the end of 2020. But they announced in November that that number had been reduced to 50 million after some of the raw materials they received didn’t meet standards. 


Check This Out: Top Drug Discovery and Development Companies


And newly released research from IBM found that hackers have attempted to carry out sophisticated phishing attacks against the companies that are preparing to help transport the vaccine at the necessary frigid temperatures, another wrinkle in what’s already a very complicated supply chain.


An updated Covid-19 forecast from the CDC made the grim prediction that the total national death toll could rise to between 303,00 and 329,000 in the next three weeks. As of Friday, approximately 267,000 Americans have died from the disease. Meanwhile, new restrictions are going into place across the country. Notably, California Governor Gavin Newsom announced the state’s strictest measures since the spring, including limiting restaurants to takeout or delivery only, and calling on residents to halt nonessential travel.


In Washington, it appears legislators might be nearing an agreement on a new, bipartisan $908 billion stimulus package, which has the support of President-elect Joe Biden. Biden also announced this week that Dr. Anthony Fauci will be a chief medical adviser in his administration, and that he plans to ask all Americans to wear masks for his first 100 days in office.


 Some research indicates that the virus might even have crossed over multiple times between bats, humans, and other animals before arriving at its current incarnation. And because it has now been around a year since the first cases of mysterious pneumonia were detected in Wuhan, we may be too far removed from the beginnings of this virus to ever know exactly how it came to be.


Weekly Brief

loading
Towards a New World Order
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/vaccine-delivery-across-the-country-faces-supply-chain-challenges-nwid-251.html